Ongoing in vivo immunoglobulin class switch DNA recombination in chronic lymphocytic leukemia B cells

被引:60
作者
Cerutti, A
Zan, H
Kim, EC
Shah, S
Schattner, EJ
Schaffer, A
Casali, P
机构
[1] Cornell Univ, Weill Med Coll, Dept Pathol, Div Mol Immunol, New York, NY 10021 USA
[2] Cornell Univ, Weill Med Coll, Dept Med, Div Hematol, New York, NY 10021 USA
[3] Cornell Univ, Weill Med Coll, Grad Sch Med Sci, Program Immunol, New York, NY 10021 USA
关键词
D O I
10.4049/jimmunol.169.11.6594
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Chronic lymphocytic leukemia (CLL) results from the expansion of malignant CD5(+) B cells that usually express IgD and IgM. These leukemic cells can give rise in vivo to clonally related IgG(+) or IgA(+) elements. The requirements and modalities of this process remain elusive. Here we show that leukemic B cells from 14 of 20 CLLs contain the hallmarks of ongoing Ig class switch DNA recombination (CSR), including extrachromosomal switch circular DNAs and circle transcripts generated by direct Smu-->Sgamma, Smu-->Salpha, and Smu-->Sepsilon as well as sequential Sgamma-->Salpha and Sgamma-->Sepsilon CSR. Similar CLL B cells express transcripts for activation-induced cytidine deaminase, a critical component of the CSR machinery, and contain germline I-H-C-H and mature V(H)DJ(H)-C-H transcripts encoded by multiple Cgamma, Calpha, and Cepsilon genes. Ongoing CSR occurs in only a fraction of the CLL clone, as only small proportions of CD5(+)CD19(+) cells express surface IgG or IgA and lack IgM and IgD. In vivo class-switching CLL B cells down-regulate switch circles and circle transcripts in vitro unless exposed to exogenous CD40 ligand and IL-4. In addition, CLL B cells that do not class switch in vivo activate the CSR machinery and secrete IgG, IgA, or IgE upon in vitro exposure to CD40 ligand and IL-4. These findings indicate that in CLL at least some members of the malignant clone actively differentiate in vivo along a pathway that induces CSR. They also suggest that this process is elicited by external stimuli, including CD40 ligand and IL-4, provided by bystander immune cells.
引用
收藏
页码:6594 / 6603
页数:10
相关论文
共 79 条
[1]   Histological and immunoglobulin VH gene analysis of interfollicular small lymphocytic lymphoma provides evidence for two types [J].
Bahler, DW ;
Aguilera, NS ;
Chen, CC ;
Abbondanzo, SL ;
Swerdlow, SH .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 157 (04) :1063-1070
[2]  
BEAUME A, 1994, BLOOD, V84, P1216
[3]   Survival of leukemic B cells promoted by engagement of the antigen receptor [J].
Bernal, A ;
Pastore, RD ;
Asgary, Z ;
Keller, SA ;
Cesarman, E ;
Liou, HC ;
Schattner, EJ .
BLOOD, 2001, 98 (10) :3050-3057
[4]  
BERTOLI LF, 1987, BLOOD, V70, P45
[5]   Identification of a tonsil IgD(+) B cell subset with phenotypical and functional characteristics of germinal center B cells [J].
Billian, G ;
Bella, C ;
Mondiere, P ;
Defrance, T .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (08) :1712-1719
[6]  
BORZILLO GV, 1987, J IMMUNOL, V139, P1326
[7]  
BORZILLO GV, 1988, J IMMUNOL, V141, P3625
[8]   B-cell chronic lymphocytic leukemia: A bird of a different feather [J].
Caligaris-Cappio, F ;
Hamblin, TJ .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) :399-408
[9]   Acquired CD40-ligand deficiency in chronic lymphocytic leukemia [J].
Cantwell, M ;
Hua, T ;
Pappas, J ;
Kipps, TJ .
NATURE MEDICINE, 1997, 3 (09) :984-989
[10]   HUMAN-LYMPHOCYTES MAKING RHEUMATOID-FACTOR AND ANTIBODY TO SSDNA BELONG TO LEU-1+ B-CELL SUBSET [J].
CASALI, P ;
BURASTERO, SE ;
NAKAMURA, M ;
INGHIRAMI, G ;
NOTKINS, AL .
SCIENCE, 1987, 236 (4797) :77-81